海爾生物(688139.SH)擬向特種電冰櫃出售原生產廠區無法遷移部分資產
格隆匯12月25日丨海爾生物(688139.SH)公佈,公司擬將位於青島開發區海爾工業園內原生產廠區的85項設備類固定資產和1項廠房改造工程形成的資產出售給特種電冰櫃,轉讓金額為人民幣1850.36萬元。上述資產在公司2019年底生產場所搬遷時,因無法遷移或遷移成本過高而不再使用,為進一步盤活公司資產、提高資產利用率,公司擬將上述資產轉讓至特種電冰櫃。
公司的主要生產場所於2019年底由青島開發區海爾工業園搬遷至青島高新區海爾生物醫療新興產業園,本次交易標的即為原生產場所的部分設備類固定資產和廠房改造工程形成的資產。由於相關設備的拆卸、轉移和再安裝成本過高,且廠房改造工程形成的資產無法遷移,公司將上述資產留在原生產場所不再使用。考慮到目前交易標的仍可正常投入使用,公司原生產場所的後續使用者特種電冰櫃願意受讓上述資產。
本次交易處置的交易標的均為公司不再使用的設備類資產及廠房改造工程所形成的資產,不會對公司正常生產經營造成不利影響。預計本次交易將增加公司税前利潤43.86萬元(具體金額及會計處理以審計結果為準),不會對公司財務狀況和經營成果造成顯著影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.